|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||
|
||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=sCCBAE2A8-5CB8-11EF-B6DB-DAD684CE164B&I=39IZM&T=&OP=Display&O=html&O1=15432437&O2=1000000000312600&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DSafety%2520and%2520Efficacy%2520of%2520Switching%2520SAR341402%2520Insulin%2520Aspart%2520and%2520Originator%2520Insulin%2520Aspart%2520vs%2520Continuous%2520Use%2520of%2520Originator%2520Insulin%2520Aspart%2520in%2520Adults%2520With%2520Type%25201%2520Diabetes%253A%2520The%2520GEMELLI%2520X%2520Trial%26rft.au%3DAl-Karadsheh%252C%2520Amer%26rft.au%3DBarnes%252C%2520Cathy%26rft.au%3DMandry%252C%2520Jose%26rft.au%3DShah%252C%2520Viral%2520N%26rft.date%3D2024-02-29%26rft.eissn%3D1932-2968%26rft.epage%3D19322968241232709%26rft.externalDBID%3DNO_FULL_TEXT%26rft.genre%3Darticle%26rft.jtitle%3DJournal%2520of%2520diabetes%2520science%2520and%2520technology%26rft.spage%3D19322968241232709%26rft_id%3Dinfo%253Adoi%252F10.1177%252F19322968241232709%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-SAGE_JOURNALS_PREMIER_2021-getFullTxt-object,2-DOI-getDOI-object,3-COBIB_SI_LCL-getHolding-object,4-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,5-REFWORKS_EXPORT_TOOL-getReference-object,6-GOOGLE_SCHOLAR_FREE-getWebSearch-object,7-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=0.866309&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15432437-sCCBAE2A8-5CB8-11EF-B6DB-DAD684CE164B" timestamp="2024-08-17T18:50:31Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:1000000000312600</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Safety and Efficacy of Switching SAR341402 Insulin Aspart and Originator Insulin Aspart vs Continuous Use of Originator Insulin Aspart in Adults With Type 1 Diabetes: The GEMELLI X Trial</jnl:atitle>
<jnl:jtitle>Journal of Diabetes Science and Technology (JDST)</jnl:jtitle>
<jnl:date>2024-02-29</jnl:date>
<jnl:spage>19322968241232709</jnl:spage>
<jnl:epage>19322968241232709</jnl:epage>
<jnl:issn>1932-2968</jnl:issn>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1932-2968</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:d1c87929d5a2279cd44a8597c0d52888a98ca5d8</ctx:identifier>
<ctx:identifier>urn:UUID:sCCBAE2A8-5CB8-11EF-B6DB-DAD684CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)